Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Pileri

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Journal of the American Academy of Dermatology|January 26, 2025
Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literatureOluwaseyi Adeuyan, Celine M Schreidah, Jeffrey W Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypesPaolo Corradini, Marco Ladetto, Francesco Zallio, et al.
Cells|August 11, 2023
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at DiagnosisSilvia Alberti-Violetti, Maria Rosaria Sapienza, Marcello Del Corvo, et al.
Experimental Dermatology|June 6, 2026
Toward Objective Wound Edge Classification in Clinical PracticeCorrado Zengarini, Tommaso Giacometti, Yuri Merli, et al.
Haematologica|December 24, 2002
Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomachStefano Aldo Pileri, Stefano Ascani, Pier Luigi Zinzani, et al.
Cancer Management and Research|November 29, 2022
Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell LymphomasLaura Caruso, Alessia Castellino, Daniela Dessì, et al.
Virchows Archiv : an International Journal of Pathology|March 22, 2017
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the diseaseAlessandro Pileri, Claudio Agostinelli, Maurizio Sessa, et al.
Dermatologic Therapy|August 14, 2020
Cutaneous adverse-events in patients treated with IbrutinibAlessandro Pileri, Alba Guglielmo, Claudio Agostinelli, et al.
British Journal of Haematology|May 25, 2002
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting systemClaudia Voena, Giovanni Locatelli, Claudia Castellino, et al.
Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Journal of the American Academy of Dermatology|January 26, 2025
Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literatureOluwaseyi Adeuyan, Celine M Schreidah, Jeffrey W Craig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypesPaolo Corradini, Marco Ladetto, Francesco Zallio, et al.
Cells|August 11, 2023
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at DiagnosisSilvia Alberti-Violetti, Maria Rosaria Sapienza, Marcello Del Corvo, et al.
Experimental Dermatology|June 6, 2026
Toward Objective Wound Edge Classification in Clinical PracticeCorrado Zengarini, Tommaso Giacometti, Yuri Merli, et al.
Haematologica|December 24, 2002
Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomachStefano Aldo Pileri, Stefano Ascani, Pier Luigi Zinzani, et al.
Cancer Management and Research|November 29, 2022
Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell LymphomasLaura Caruso, Alessia Castellino, Daniela Dessì, et al.
Virchows Archiv : an International Journal of Pathology|March 22, 2017
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the diseaseAlessandro Pileri, Claudio Agostinelli, Maurizio Sessa, et al.
Dermatologic Therapy|August 14, 2020
Cutaneous adverse-events in patients treated with IbrutinibAlessandro Pileri, Alba Guglielmo, Claudio Agostinelli, et al.
British Journal of Haematology|May 25, 2002
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting systemClaudia Voena, Giovanni Locatelli, Claudia Castellino, et al.
Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.
Pageof 17